Evaluation CA15-3, Blood Urea and Creatinine in Breast Cancer Comen

Abstract

The current study was conducted on 90 women divided into three groups: G1 included 30 women with breast cancer, and G2 included 30 women with breast cancer that received a single dose of treatment and 30 women as the control group (healthy), the ages of the groups ranged between (27-25) years, as the samples were collected from the Oncology Hospital of the Medical City in Baghdad Governorate, for the period between 1/11/2022 to 1/2/ 2023. Where about 5 ml of blood was collected from the blood of the groups of patients as well as from healthy women and the samples were divided based on the type of test, after placing them in jell tubes free of anticoagulant and leaving the blood at a temperature of 25 ° C until it coagulates and then placed in a centrifuge for 10 minutes at a speed of 3000 cycles/minute and then the serum was obtained and then placed in Eppendorf and kept in deep freezer at a temperature of -20 ° C for the purpose of Measure the levels of CA15-3 urea and creatinine in s with breast cancer women.

The results of the current research showed a significant increase in the cancer antigen CA15-3 in the serum of G1 and G2, compared to the control group with a significant decrease in the G2 group compared to G1, while urea and creatinine showed a significant increase in the serum of G2compared to G1 and healthy women.